ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr | ₹3,604 Cr | ₹3,245 Cr |
What is the latest Total Current Liabilities ratio of ALKEM LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹3,995 Cr |
Mar2023 | ₹3,707 Cr |
Mar2022 | ₹4,805 Cr |
Mar2021 | ₹3,604 Cr |
Mar2020 | ₹3,245 Cr |
How is Total Current Liabilities of ALKEM LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3,995 Cr | 7.75 | |
Mar2023 | ₹3,707 Cr | -22.85 | |
Mar2022 | ₹4,805 Cr | 33.33 | |
Mar2021 | ₹3,604 Cr | 11.08 | |
Mar2020 | ₹3,245 Cr | - |
Compare Total Current Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹56,313.7 Cr | -10.4% | -9.5% | -8.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -2.8% | -3.6% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.5% | 1.5% | 59.1% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | -1.5% | 0.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.6% | -9.2% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,002.4 Cr | -7.4% | -5.1% | 9.9% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | -10.4% |
-9.5% |
-8.5% |
SENSEX | -2.7% |
-0.4% |
6.4% |
You may also like the below Video Courses